Correlation Between Software And and Biotechnology Portfolio

Can any of the company-specific risk be diversified away by investing in both Software And and Biotechnology Portfolio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Software And and Biotechnology Portfolio into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Software And It and Biotechnology Portfolio Biotechnology, you can compare the effects of market volatilities on Software And and Biotechnology Portfolio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Software And with a short position of Biotechnology Portfolio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Software And and Biotechnology Portfolio.

Diversification Opportunities for Software And and Biotechnology Portfolio

0.81

Correlation Coefficient

Software And  Biotechnology Portfolio

Very poor diversification

The 3 months correlation between Software and Biotechnology is 0.81. Overlapping area represents the amount of risk that can be diversified away by holding Software And It and Biotechnology Portfolio Biotec in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biotechnology Portfolio and Software And is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Software And It are associated (or correlated) with Biotechnology Portfolio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biotechnology Portfolio has no effect on the direction of Software And i.e., Software And and Biotechnology Portfolio go up and down completely randomly.

Pair Corralation between Software And and Biotechnology Portfolio

Assuming the 90 days horizon Software And is expected to generate 2.54 times less return on investment than Biotechnology Portfolio. But when comparing it to its historical volatility, Software And It is 1.18 times less risky than Biotechnology Portfolio. It trades about 0.07 of its potential returns per unit of risk. Biotechnology Portfolio Biotechnology is currently generating about 0.15 of returns per unit of risk over similar time horizon. If you would invest  1,741  in Biotechnology Portfolio Biotechnology on May 10, 2025 and sell it today you would earn a total of  197.00  from holding Biotechnology Portfolio Biotechnology or generate 11.32% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Strong
Accuracy	100.0%
Values	Daily Returns

Software And It  vs.  Biotechnology Portfolio Biotec

Software And It

Risk-Adjusted Performance

Mild

Compared to the overall equity markets, risk-adjusted returns on investments in Software And It are ranked lower than 5 (%) of all funds and portfolios of funds over the last 90 days. In spite of fairly strong basic indicators, Software And is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Biotechnology Portfolio

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Biotechnology Portfolio Biotechnology are ranked lower than 11 (%) of all funds and portfolios of funds over the last 90 days. In spite of fairly weak basic indicators, Biotechnology Portfolio may actually be approaching a critical reversion point that can send shares even higher in September 2025.

Pair Trading with Software And and Biotechnology Portfolio

The main advantage of trading using opposite Software And and Biotechnology Portfolio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Software And position performs unexpectedly, Biotechnology Portfolio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biotechnology Portfolio will offset losses from the drop in Biotechnology Portfolio's long position.

The idea behind Software And It and Biotechnology Portfolio Biotechnology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.